International Myeloma Workshop 2019
International Myeloma Workshop 2019
Advertisement
DocWire News EditorsInternational Myeloma Workshop 2019 | April 24, 2023
Whole-body MRI (WBMRI) is significantly more sensitive than PET/CT at detecting bone marrow involvement (BMI) in ...
Read More
DocWire News EditorsInternational Myeloma Workshop 2019 | October 22, 2019
Patients with gammopathy of undetermined significance (MGUS) were unable to be classified by bone mineral density (BMD) ...
DocWire News EditorsInternational Myeloma Workshop 2019 | October 22, 2019
Independent predictors of early relapse multiple myeloma (MM) include TP53 mutation, high LDH levels, amp1q and IGLL5 ...
DocWire News EditorsInternational Myeloma Workshop 2019 | October 22, 2019
Researchers of a study presented at the 17th International Myeloma Workshop are aiming to characterize the longitudinal ...
DocWire News EditorsInternational Myeloma Workshop 2019 | October 3, 2019
The triple combination of carflizomib, pomalidomide, and dexamethasone (KPd) is an effective, and well-tolerated option ...
DocWire News EditorsInternational Myeloma Workshop 2019 | April 20, 2023
The results of a study presented at the 17th International Myeloma Workshop might provide the rational for predicting ...
DocWire News EditorsInternational Myeloma Workshop 2019 | October 3, 2019
There exists a higher rate of multiple myeloma (MM) progression in younger patients with smoldering multiple myeloma ...
DocWire News EditorsInternational Myeloma Workshop 2019 | October 3, 2019
Multiple myeloma (MM) patients with a fracture at diagnosis have a higher risk of dying compared to patients without a ...
DocWire News EditorsInternational Myeloma Workshop 2019 | September 30, 2019
Researchers have uncovered that both T cell-intrinsic and microenvironment factors are associated with clinical response ...
DocWire News EditorsInternational Myeloma Workshop 2019 | September 30, 2019
This early-stage clinical study, presented at the 17th International Myeloma Workshop, exhibited the safety and efficacy ...
DocWire News EditorsInternational Myeloma Workshop 2019 | September 30, 2019
Resistance to BRAF inhibition in vitro is mediated by the two distinct mechanisms of clonal outgrowth of genetically ...
DocWire News EditorsInternational Myeloma Workshop 2019 | September 30, 2019
PHD finger protein 1 9(PHF19), represents a potential therapeutic target to overcome drug resistance and improve ...
Advertisement
Advertisement
Advertisement
Latest News

January 7, 2025